INNOVATION
CSL urges biotech immunity from policy see-saws
SYDNEY: Australian biotech giant CSL’s chief scientific officer, Andrew Cuthbertson, has warned a future Labor… read more
ResMed makes $305m US asthma tech buy
SYDNEY: ResMed chief executive Mick Farrell says the acquisition of an innovative start-up that helps… read more
Australian Govt $240m shot for medical research
CANBERRA: The Morrison government will today begin accepting applications for a $240 million program it… read more
